Clinical Trial Update: Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating atezolizumab in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma, Gliosarcoma | Phase 1, Phase 2 | Status: COMPLETED